Editorial: Epigenetic mechanisms and epigenetic-based therapies in cardiometabolic and vascular disease

Yanshuo Han; Chen Chen; Jian Zhang

doi:10.3389/fgene.2023.1233096

Editorial: Epigenetic mechanisms and epigenetic-based therapies in cardiometabolic and vascular disease

Front Genet. 2023 Jun 23:14:1233096. doi: 10.3389/fgene.2023.1233096. eCollection 2023.

Authors

Yanshuo Han¹, Chen Chen², Jian Zhang³

Affiliations

¹ School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
² School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.
³ Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, China.

No abstract available

Keywords: abdominal aort aneurysm; cardiometabolic and vascular disease; epigenectic regulation; epigenetic therapeutics; noncoding RNA.

Publication types

Editorial

Grants and funding

This study was supported by the Fundamental Research Funds for the Central Universities (grant number: DUT19RC(3)076 and DUT22YG107), the National Natural Science Foundation of China (grant numbers: 81600370), the National Natural Science Foundation of Liaoning Province (2023-MS-096) and the China Postdoctoral Science Foundation (grant number: 2018M640270) for YH. This research was also funded by the National Natural Science Foundation of China (grant numbers: 82103056 and 81970402) for JZ.